SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: American Spirit who wrote (8003)6/29/1999 2:37:00 PM
From: Money Maker (MM)  Respond to of 9523
 
The momentum is on PFE, stock split and after that, ER!...:)

MM



To: American Spirit who wrote (8003)6/29/1999 5:04:00 PM
From: John F. Dowd  Read Replies (1) | Respond to of 9523
 
AS and All: Trovan will come back. It was never intended as a broad spectrum everyday anti-biotic but was to be used in a hospital environment and closely monitored. This is a silver bullet last resort pill much like others out there that have the same side effects. PFE was victim of bad PR on that one and they had better sharpen up those skills as they introduce more new drugs. JFD


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News